Health & Environmental Research Online (HERO)


Print Feedback Export to File
224589 
Journal Article 
Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells 
Moore, MM; Amtower, A; Doerr, C; Brock, KH; Dearfield, KL 
1987 
Yes 
Environmental Mutagenesis
ISSN: 0192-2521
EISSN: 1930-238X 
9 
3 
261-267 
Acrylamide was tested without exogenous activation in L5178Y/TK+/- -3.7.2C cells for mutation at the thymidine kinase locus and for clastogenicity. Acrylamide gave a positive induced mutagenic response (approximately 70 mutants/10(6) survivors) when tested at 600-650 micrograms/ml. The highest dose tested (850 micrograms/ml) resulted in an induced mutant frequency of approximately 380 mutants/10(6) survivors (survival = 13%). Acrylamide induced almost exclusively small-colony mutants, indicating that it might be acting by a clastogenic mechanism. As predicted, acrylamide was clastogenic, inducing both chromatid and chromosome breaks and rearrangements. A clearly positive clastogenic response was observed at both the 750 micrograms/ml and 850 micrograms/ml doses, which showed 16 and 64 aberrations per 100 cells, respectively (background = 3 aberrations per 100 cells). These studies indicate that the L5178Y/TK+/- mouse lymphoma assay can detect some chromosomal mutagens (clastogens) that show little activity in other single gene mutation assays, the CHO/HPRT and Salmonella. 
acrylamide; L5178Y mouse lymphoma assay; gene mutation; thymidine kinase locus; chromosome aberrations